|
Part returned.(b)(4).The investigation could not be completed; no conclusion could be drawn at the time of filing this report.A review of the device history record has been requested.The device was received, the investigation is in progress, no conclusion could be drawn at the time of filing this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
It was reported that on (b)(6) 2019, the patient underwent trochanteric femoral nail (tfn) revision surgery due to severe pain at the site of breakage.The trochanteric femoral nail-advanced (tfna) devices were originally implanted on (b)(6) 2018, for a peri trochanteric fracture using a nail size of 11 x 420 left with a 105 screw.There was additional medical intervention performed to the patient having prescriptions and physical therapy.Fragments generated from the broken device and was difficult to remove due to broken nail in two pieces.It was unknown if there was a surgical delay.Procedure outcome was unknown.There was a patient consequence.Concomitant devices reported: tfna fenestrated screw (part #: 04.038.205, lot #: h452577, quantity #: 1), unknown locking screws (part # unknown, lot # unknown, quantity unknown).This complaint involves one (1) device.This report is 1 of 1 for (b)(4).
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.A device history record (dhr) review was conducted: manufacturing location: monument, manufacturing date: 27-mar-2018, expiration date: 28-feb-2028, part number: 04.037.163s, 11mm/130 deg ti cann tfna 420mm / left ¿ sterile, lot number: h597038 (sterile), lot quantity: (b)(4).This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Component parts reviewed: part number: 04.037.942.2, lock prong, 130 degree, tfna bp55, lot number: l634505, lot quantity: (b)(4).Purchased finished goods travelers met all inspection acceptance criteria.Part number: 04.037.912.4, wave spring, shim ended bp55, lot number: h529578, lot quantity: (b)(4).Work order traveler met all inspection acceptance criteria.Part number: 04.037.912.3, tfna lock drive bp58, lot number: h556414, lot quantity: (b)(4).Work order traveler met all inspection acceptance criteria.Inspection sheet ns062925 rev e met all inspection acceptance criteria.Part number: 21127, timoagri16.00 bp80, lot number: h381834, lot quantity: (b)(4).This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.A product investigation was conducted.Visual inspection: 11mm/130 deg ti cann tfna 420mm/left ¿ sterile was received at cq.Upon visual inspection at cq, it is observed that the nail is broken at its proximal head part.There are some discolored spots on the surface of the device.Thus, the reported complaint is confirmed.The received condition does agree with the complaint description.Dimensional inspection: dimensional inspection cannot be performed due to post manufacturing damage.Document/ specification review: the relevant drawing(s) was reviewed; no design issues or discrepancies were found during this investigation.Investigation conclusion: visual inspection, and document specification review of the received device was performed at cq.The complaint is confirmed.A definitive root cause could not be determined.During the investigation no unidentified product design/manufacturing issues or discrepancies were observed that may have contributed to the complaint condition.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|